In conclusion, for the first time, the present study has demonstrated that QC inhibits angiogenesis in prostatic tissue of BPH rats via the inhibition of the HIF-1α signaling pathway, which may in part explain the mechanism underlying the activity of QC in BPH treatment. Here, HIF1A is linked to benign prostatic hyperplasia.